Option 3
Option 3 is a medical device development and commercialization vehicle formed by Research Corporation Technoliogies and James Dreher to invest in the development and commercialization of select medical device products that are not technically complex, capital intensive to develop or require significant clinical data to be approved and marketed.
Option 3's first investment is in Axiom Technology Partners, LLC, a company formed in 2010 to develop and commercialize a novel fascial closure device.
Contact
James Dreher, Option 3 President and CEO
Christopher P. Martin, RCT Senior Vice President and CFO